Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Celularity Inc entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (effective 2023-04-04).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- A.G.P./Alliance Global Partners
- Effective
- 2023-04-04
Exact text from the filing
In connection with the Purchase Agreement, Celularity entered into a placement agency agreement, or Placement Agency Agreement, with A.G.P./Alliance Global Partners, or A.G.P., pursuant to which A.G.P. agreed to serve as exclusive placement agent for the issuance and sale of the shares of Class A common stock and accompanying warrants.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Celularity Inc entered into Purchase Agreement with institutional accredited investor valued at approximately $6.0 million (effective 2023-04-04).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- institutional accredited investor
- Value
- approximately $6.0 million
- Effective
- 2023-04-04
Exact text from the filing
On April 4, 2023, Celularity Inc, or Celularity, entered into a securities purchase agreement with an institutional accredited investor, or the Purchase Agreement, providing for the sale and issuance of (i) 9,230,770 shares of its Class A common stock, par value $0.0001 per share, or the Class A common stock, and (ii) accompanying warrants to purchase up to 9,230,770 shares of Class A common stock, at a combined purchase price of $0.65 per share and accompanying warrant, for an aggregate purchase price of approximately $6.0 million.
View on SEC.gov